Where does Refocus Group, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Refocus Group, Inc. ranks #17,117 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Refocus Group, Inc. hold?

Refocus Group, Inc. holds 17 US utility patents granted between 2015 and 2023, spanning 3 technology areas.

What is Refocus Group, Inc.'s Innovation Score?

Refocus Group, Inc. has an Innovation Score of 31.2 out of 100 (37th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Refocus Group, Inc. focus on?

Refocus Group, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 17 patents, ranking #1,046 of 7,127 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Refocus Group, Inc.'s patent grant rate increasing or decreasing?

Refocus Group, Inc.'s recent grant velocity is -58% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Refocus Group, Inc.'s patents?

Refocus Group, Inc.'s patents average 20.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Refocus Group, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Refocus Group, Inc.

USPTO PatentsView assignee record - 17 granted patents across 3 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Refocus ranks #17,117 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 3 technology areas.

#17,117
of 49,997 US assignees by volume: 37th percentile
by Innovation Score (31.2/100): 20.8
avg claims per patent: -58%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R17117 · US Corporation #17,117 · 17 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 17 grants
MID-PACK #17,117/49,997
PHOTO-FINISH Reinke Manufacturing
CPC-NARROW A61B · 3 areas
INNOV-THIN 31.2/100
CLAIMS-DENSE 20.8 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -58% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Reinke Manufacturing Company, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Refocus’s 31.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.0 pts (32%) Velocity 2.7 pts (9%) Breadth 6.1 pts (19%) Claim depth 12.5 pts (40%)

Qualcomm Incorporated · highest

85
Refocus Group · this assignee

31
3D Lighting… · lowest

7

What this shows Refocus's Innovation Score is 31.2/100 (37th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Refocus?

Each dot is one of Refocus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Refocus’s own 20.8 claims/patent is ABOVE the 13.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Refocus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Refocus's grants concentrate

Refocus Group, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2017 (5 grants) versus a trough of 1 in 2015. By volume, Refocus sits between Roam Robotics Inc. and Revogenex Ireland Ltd.

Refocus's three-year grant acceleration

Refocus Group, Inc. shows 2 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Roam Robotics

17
Roberto Coin S P A

17
Roswell Canada

17
Rothenberger

17
Reinke Manufactur…

17
Relay

17
Reliance Medical…

17
Revogenex Ireland

17
Refocus Group ◀

17

What this shows Refocus holds 17 patents at rank #17,124, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Refocus

By rank, the assignees closest to #17,124 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Refocus's primary technology class.

Refocus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 37th percentile higher than 37% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Refocus Group, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	5.9%
2016	4	23.5%
2017	5	29.4%
2019	2	11.8%
2020	3	17.6%
2022	1	5.9%
2023	1	5.9%

Which technologies does Refocus Group, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 17

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 17

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 12

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Refocus Group, Inc.'s patent record in context - here's where to go next.

Refocus Group, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #17,117 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Refocus Group, Inc. against Roam Robotics Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.